Trial Details
RECRUITINGBasic Information
| Clinical ID | c1269 |
|---|---|
| Identifier | NCT06254950 |
| Trial Title | A Study on the Safety of TAK-279 and Whether it Can Reduce Inflammation in the Bowel of Participants With Moderately to Severely Active Ulcerative Colitis |
| Trial URL | Visit Original Page |
Study Information
| Study Results | NO |
|---|---|
| Conditions | Ulcerative Colitis |
| Interventions | DRUG: TAK-279|DRUG: Placebo |
Participant Information
| Sponsor | Takeda |
|---|---|
| City | Los Angeles |
| Country/Region | United States |
Enrollment Criteria
| Sex Requirement | ALL |
|---|---|
| Age Requirement | ADULT, OLDER_ADULT |
Study Design
| Study Type | INTERVENTIONAL |
|---|---|
| Phase | PHASE2 |
Time Information
| Start Date | 2024-03-29 |
|---|---|
| Primary Completion Date | 2026-09-30 |
| Completion Date | 2027-08-04 |